Melanoma survivors: could immunotherapy harm your heart years later?
NCT ID NCT06605833
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether melanoma patients who received immunotherapy might have heart problems years later. Researchers will invite 60 people who finished treatment 2 to 10+ years ago to undergo heart tests. The goal is to see if it's possible to study these long-term side effects, which could lead to better follow-up care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA STAGE III OR IV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Royal Marsden NHS Foundation Trust
London, SW6 3JJ, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.